This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Teladoc to Buy InTouch Health, Expand Reach in Virtual Care
by Zacks Equity Research
Teladoc (TDOC) to acquire InTouch Health and provide virtual health solutions ranging from critical to everyday care.
Here's Why You Should Add Cerner (CERN) to Your Portfolio
by Zacks Equity Research
Cerner (CERN) expects revenues between $1.41 billion and $1.46 billion in the fourth quarter.
Here's Why You Should Hold on to AngioDynamics Stock Now
by Zacks Equity Research
AngioDynamics (ANGO) retains fiscal 2020 view; VA revenues soft in fiscal Q2.
Walgreens Boots (WBA) Q1 Earnings Lag Estimates, Margins Fall
by Zacks Equity Research
Sluggishness in Walgreens Boots' (WBA) Retail Pharmacy International segment and margin contractions put pressure on the bottom line during Q1.
AngioDynamics (ANGO) Q2 Earnings Top, Revenues Lag Estimates
by Zacks Equity Research
AngioDynamics (ANGO) gains from core Oncology business in the fiscal second quarter, reiterates guidance.
Walgreens Boots (WBA) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Higher comparable pharmacy sales and expanded comparable prescription volume are likely to have aided growth in Walgreens Boots' (WBA) Retail Pharmacy USA during the first quarter of fiscal 2020.
Here's Why You Should Hold on to Becton, Dickinson Stock Now
by Zacks Equity Research
Becton, Dickinson (BDX) expects fiscal 2020 revenue growth to be driven by recent product launches.
New Strong Buy Stocks for December 30th
by Tirthankar Chakraborty
Here are 4 stocks added to the Zacks Rank #1 (Strong Buy) List for today:
Top Ranked Momentum Stocks to Buy for December 30th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, December 30th
ERFSF or HQY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ERFSF vs. HQY: Which Stock Is the Better Value Option?
HMS Holdings Acquires Nebraska-Based Intrado's Accent Unit
by Zacks Equity Research
The latest deal is likely to boost HMS Holdings' (HMSY) Payment Integrity solutions business.
Here's Why You Should Hold on to Masimo (MASI) Stock Now
by Zacks Equity Research
Masimo (MASI) raises revenue and earnings guidance for 2019.
Why HealthEquity (HQY) Could Be an Impressive Growth Stock
by Shivangi Deora
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider HealthEquity (HQY).
Is HealthEquity (HQY) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (HQY) Outperforming Other Medical Stocks This Year?
Masimo (MASI) Expands Partnership with Texas-Based Drager
by Zacks Equity Research
Masimo (MASI) sees a slew of developments in recent times.
Hill-Rom (HRC) Rides on International Growth, New Launches
by Urmimala Biswas
Hill-Rom (HRC) launches RetinaVue 700 Imager, EarlySense and WatchCare in 2019.
LHC Group Expands Partnership With Ochsner Health System
by Zacks Equity Research
LHC Group (LHCG) sees major expansion in partnerships of late.
Here's Why You Should Add DexCom (DXCM) to Your Portfolio
by Zacks Equity Research
DexCom (DXCM) raises its 2019 revenue and EPS guidance.
LHC Group Expands Partnership With Tennessee-Based Medalogix
by Zacks Equity Research
Management at LHC Group (LHCG) expects to complete the expansion by the first quarter of 2020.
Will HealthEquity Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor HealthEquity.
3 Stocks to Consider as Retail Spending Slows
by Christopher Vargas
The stock market saw tepid movement Friday after the US struck a phase one deal with China.
McKesson, Walgreens Form JV for European Pharmaceutical Unit
by Zacks Equity Research
The VA selects McKesson (MCK) as their prime pharmaceutical supplier.
LHC Group Set to Gain From Expansion of LifePoint Health JV
by Zacks Equity Research
LHC Group (LHCG) expects approximately $5.4 million in annualized revenues from this transaction.
ERFSF vs. HQY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ERFSF vs. HQY: Which Stock Is the Better Value Option?
Here's Why You Should Hold on to Ecolab (ECL) Stock for Now
by Zacks Equity Research
Ecolab (ECL) slashes 2019 EPS view owing to foreign exchange headwinds.